Denise Kandel, PhD., Head of the Department of Epidemiology of Substance Abuse at the New York State Psychiatric Institute, Professor of Sociomedical Sciences and Psychiatry at Columbia University. Major interests: the epidemiology, risk factors, and consequences of drug use, in particular smoking and prescription opioid use; the epidemiology of substance dependence; developmental pathways of problem behaviors in adolescence; the intergenerational transmission of deviance; animal models of epidemiological paradigms.
Current research activities focus on five areas: 1) the epidemiology of prescription opioid use and mortality; 2) the Gateway Hypothesis of drug involvement; 3) the intergenerational effects of parental drug use on child drug behavior and development; 4) epidemiology of post-traumatic stress disorder; 5) animal models of the Gateway Hypothesis.
The epidemiology, risk factors, and consequences of drug use, in particular smoking and prescription opioid use; the epidemiology of substance dependence; developmental pathways of problem behaviors in adolescence; the intergenerational transmission of deviance; animal models of epidemiological paradigms.
Current research activities focus on five areas: 1) the epidemiology of prescription opioid use and mortality; 2) the Gateway Hypothesis of drug involvement; 3) the intergenerational effects of parental drug use on child drug behavior and development; 4) epidemiology of post-traumatic stress disorder; 5) animal models of the Gateway Hypothesis.
For a complete list of publications, please visit PubMed.gov(link is external and opens in a new window)
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.
